Your browser doesn't support javascript.
loading
Association between obstructive sleep apnea and visceral adiposity index and lipid accumulation product: NHANES 2015-2018.
Zhou, Tingfeng; Chen, Shihao; Mao, Jiesheng; Zhu, Pei; Yu, Xinru; Lin, Renyu.
Afiliação
  • Zhou T; Department of Otolaryngology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Chen S; Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Mao J; Department of Neurology, Postgraduate Training Base Alliance of Wenzhou Medical University (WenzhouPeople's Hospital), Wenzhou, China.
  • Zhu P; Department of Ophthalmology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Yu X; Department of Otolaryngology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Lin R; Department of Otolaryngology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. linrenyu@163.com.
Lipids Health Dis ; 23(1): 100, 2024 Apr 10.
Article em En | MEDLINE | ID: mdl-38600516
ABSTRACT

BACKGROUND:

Obesity refers to a significant contributor to the development of obstructive sleep apnea (OSA). Early prediction of OSA usually leads to better treatment outcomes, and this study aims to employ novel metabolic markers, visceral adiposity index (VAI), and lipid accumulation product (LAP) to evaluate the relationship to OSA.

METHODS:

The data used in the current cross-sectional investigation are from the National Health and Nutrition Examination Survey (NHANES), which was carried out between 2015 and 2018. To examine the correlation between LAP and VAI levels and OSA, multivariate logistic regression analysis was adopted. In addition, various analytical methods were applied, including subgroup analysis, smooth curve fitting, and threshold effect analysis.

RESULTS:

Among totally 3932 participants, 1934 were included in the OSA group. The median (Q1-Q3) values of LAP and VAI for the participants were 40.25 (21.51-68.26) and 1.27 (0.75-2.21), respectively. Logistic regression studies indicated a positive correlation between LAP, VAI, and OSA risk after adjusting for potential confounding variables. Subgroup analysis revealed a stronger correlation between LAP, VAI levels, and OSA among individuals aged < 60 years. Through smooth curve fitting, specific saturation effects of LAP, VAI, and BMD were identified, with inflection points at 65.684 and 0.428, respectively.

CONCLUSION:

This study demonstrates that elevated levels of LAP and VAI increase the risk of OSA, suggesting their potential as predictive markers for OSA and advocating for dietary and exercise interventions to mitigate OSA risk in individuals with high LAP and VAI levels.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Produto da Acumulação Lipídica Limite: Humans Idioma: En Revista: Lipids Health Dis Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Produto da Acumulação Lipídica Limite: Humans Idioma: En Revista: Lipids Health Dis Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China